Clinical Trial Update: Study to Evaluate Efficacy and Safety of Imiglucerase Treatment in Chinese Patients With Gaucher Disease Type Ⅲ [Phase 4]

View source ↗

Summary

A Phase 4 study assessing the efficacy and safety of imiglucerase in Chinese patients with Gaucher disease type III has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gaucher Disease

Drugs mentioned

• CEREZYME (imiglucerase)

Snippet

Sponsor: Sanofi | Conditions: Gaucher's Disease | Phase 4 | Status: COMPLETED